Nature reviews. Drug discovery
Novartis pays US$12 billion for Avidity's lead antibody-oligonucleotide drugs.
Asher Mullard
Published: 202510.1038/d41573-025-00182-z
No abstract available for this study.
Asher Mullard
No abstract available for this study.